Renal manifestations of primary mitochondrial disorders

Josef Finsterer1, Fulvio Alexandre Scorza2

  • 1Neurological Department, Municipal Hospital Rudolfstiftung, A-1030 Vienna, Austria.

Biomedical Reports
|May 19, 2017
PubMed

Insights

Primary mitochondrial disorders (MIDs) can affect the kidneys, leading to various renal manifestations. Early recognition and management of these kidney issues are crucial for improving patient outcomes in MIDs.

Area of Science:

  • Nephrology
  • Genetics
  • Internal Medicine

Background:

  • Primary mitochondrial disorders (MIDs) are a group of genetic diseases affecting cellular energy production.
  • Renal manifestations in MIDs are often overlooked, despite their potential impact on patient prognosis.
  • Mitochondrial multiorgan disorder syndrome (MIMODS) highlights the systemic nature of these conditions.

Purpose of the Study:

  • To review and synthesize existing literature on renal manifestations of primary mitochondrial disorders.
  • To underscore the frequency and spectrum of kidney involvement in various MIDs.
  • To emphasize the importance of recognizing and managing renal complications in MID patients.

Main Methods:

  • A comprehensive literature review was conducted using major scientific databases.
  • Findings from previous studies on renal involvement in primary MIDs were systematically summarized.

Main Results:

  • Renal manifestations in MIDs are diverse, including renal insufficiency, nephrolithiasis, nephrotic syndrome, and various tubular and glomerular diseases.
  • Syndromic MIDs, such as MELAS, Kearns-Sayre, Leigh syndrome, and mitochondrial depletion syndromes, frequently exhibit renal involvement.
  • The actual frequency of renal involvement in MIDs may be underestimated in clinical practice.

Conclusions:

  • Renal manifestations are a significant, though often underrecognized, feature of primary mitochondrial disorders.
  • Appropriate diagnosis and symptomatic management of renal complications are essential for optimizing outcomes in MID patients.
  • Increased awareness and systematic evaluation for renal involvement are warranted in the clinical management of MIDs.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
807
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.0K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
17.5K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
19.3K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
18.0K